Morgan Stanley analyst Ronald Kamdem lowered the firm’s price target on Lineage (LINE) to $95 from $100 and keeps an Overweight rating on the shares after updating the firm’s FY24, FY25 and FY26 AFFO estimates.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LINE: